Prostate cancer decisions — 2025

The Board denied service connection for multiple conditions, including hyperlipidemia, low testosterone, epididymitis, ED, prostatectomy, a mass of the parotid gland, prostate cancer, stress urinary incontinence, and other related conditions.

The Board denied the veteran's appeal for service connection claims due to untimely filings and lack of good cause.

The appeal for service connection for prostate cancer and an acquired psychiatric condition was dismissed due to a pending Higher Level Review (HLR) request.

The Board remands the claims for service connection for various disabilities, including foot, ankle, knee, elbow, leg varicose veins, colon cancer, prostate disability, and psychiatric disability, to correct pre-decisional duty to assist omissions.

The Board remands the claim for service connection of prostate cancer to obtain a new medical opinion as the previous one was deemed inadequate.

The Board remands the claims for service connection for hypertension, peptic ulcers, prostate cancer, and valvular heart disease due to inadequate VA examinations that did not consider the Veteran's exposure to ionizing radiation.

The Board remands the claims for service connection for a mental health disorder, substance use/abuse disorder, prostate cancer, sleep apnea, and bilateral hearing loss due to insufficient evidence in the record.

The Board remands the claims for service connection for hypertension and prostate cancer status post prostatectomy as additional development is needed.

The Veteran was granted a 10 percent initial rating for hypertension and special monthly compensation at the rate authorized by 38 U.S.C. § 1114(m), (n), and (r)(1) effective from August 10, 2022, to November 7, 2024.

The Board denied increased ratings for various service-connected conditions, including prostate cancer, left lung residuals, tinnitus, hearing loss, erectile dysfunction, and abdominal scar. Service connection was granted for headaches secondary to tinnitus.

The Veteran's claim for a disability evaluation in excess of 60 percent for prostate cancer residuals with voiding dysfunction was denied, while his TDIU claim beginning on August 28, 2015, was granted.

The Board denied the restoration of a 100 percent rating for prostate cancer, effective February 1, 2025, due to an improvement in the Veteran's condition.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board granted a separate initial 20 percent rating for right knee meniscal tear based on limitation of knee flexion, and an initial 60 percent rating for arteriosclerotic heart disease. It also granted TDIU due to service-connected residuals of prostate cancer.

The Board denied an increased rating in excess of 40 percent for residuals of prostate cancer and remanded the issue of a compensable disability rating for incisional hernia status post prostatectomy.

The Board granted increased ratings for dermatitis and central serous chorioretinopathy, while denying restoration of the rating for prostate cancer and granting SMC for loss of a creative organ.

The Board remands the claims for service connection for prostate cancer, erectile dysfunction, and residuals of left rib cage contusion to obtain a new VA medical opinion.

The Board granted readjudication of the claims for service connection for PTSD and depression, but denied service connection for DMII, hypertension, prostate cancer, sleep apnea, impotence, peripheral neuropathy, and bilateral claudication/superficial femoral artery disease.

The appeal regarding the proposed reduction of a 100 percent disability rating for service-connected voiding dysfunction as a residual of prostate cancer to 20 percent is dismissed.

The Board denied the Veteran's claim for a temporary total evaluation of 100 percent for prostate cancer from June 1, 2009, to August 1, 2009.